115 related articles for article (PubMed ID: 7474324)
1. [Antimicrobial activities of norfloxacin against clinical isolates from ocular infections].
Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Deguchi K; Oda S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1995 Aug; 48(8):1009-25. PubMed ID: 7474324
[TBL] [Abstract][Full Text] [Related]
2. [Antibacterial activities of ofloxacin against recent isolates from patients with community-acquired infections].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1991 Sep; 44(9):941-57. PubMed ID: 1960856
[TBL] [Abstract][Full Text] [Related]
3. [Antimicrobial activity of cefodizime against clinical isolates].
Suzuki Y; Ishihara R; Ishii Y; Nakazawa A; Deguchi K; Matsumoto Y; Nishinari C; Nakane Y; Fukumoto T
Jpn J Antibiot; 1996 Oct; 49(10):947-65. PubMed ID: 8986558
[TBL] [Abstract][Full Text] [Related]
4. [Antibacterial activities of monobactams against fresh clinical isolates].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
[TBL] [Abstract][Full Text] [Related]
5. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
[TBL] [Abstract][Full Text] [Related]
6. [Antimicrobial activity of ofloxacin against recent clinical isolates from otitis media and otitis externa].
Matsumoto Y; Suzuki Y; Ishii Y; Ishihara R; Nakazawa A; Nakane Y; Nishinari C; Deguchi K
Jpn J Antibiot; 1998 Sep; 51(9):561-75. PubMed ID: 9846283
[TBL] [Abstract][Full Text] [Related]
7. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
8. [The drug susceptibility pattern of the presumed etiologic agents of infectious enteritis including verotoxin-producing Escherichia coli O-157].
Deguchi K; Suzuki Y; Ishihara R; Ishii Y; Nakazawa A
Jpn J Antibiot; 1997 Oct; 50(10):829-43. PubMed ID: 9412873
[TBL] [Abstract][Full Text] [Related]
9. [Laboratory and clinical studies on norfloxacin in the pediatric field].
Toyonaga Y; Koizumi M; Imai H; Sakaguchi N; Sugita M; Fukushima Y; Yamasaki M
Jpn J Antibiot; 1990 May; 43(5):808-25. PubMed ID: 2391752
[TBL] [Abstract][Full Text] [Related]
10. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
[TBL] [Abstract][Full Text] [Related]
11. [Antibacterial activity of ciprofloxacin against fresh clinical isolates from superficial suppurative foci].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
Jpn J Antibiot; 1991 Feb; 44(2):117-29. PubMed ID: 2041153
[TBL] [Abstract][Full Text] [Related]
12. [Studies of lomefloxacin in biliary tract infections].
Ono Y; Kunii O
Jpn J Antibiot; 1989 Apr; 42(4):1017-24. PubMed ID: 2769934
[TBL] [Abstract][Full Text] [Related]
13. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
Jpn J Antibiot; 1996 Feb; 49(2):107-43. PubMed ID: 8721076
[TBL] [Abstract][Full Text] [Related]
14. [Laboratory and clinical studies on norfloxacin in pediatrics].
Sato Y; Iwata S; Akita H; Sunakawa K
Jpn J Antibiot; 1990 May; 43(5):826-36. PubMed ID: 2391753
[TBL] [Abstract][Full Text] [Related]
15. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1995)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kawaguchi H; Shimizu Y; Matsumiya H; Saito A; Terai T; Inoue H; Nakadate T; Ito C; Yosida T; Tanno Y; Ohno I; Nishioka K; Arakawa M; Igarashi K; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Touyama M
Jpn J Antibiot; 1997 May; 50(5):421-59. PubMed ID: 9212366
[TBL] [Abstract][Full Text] [Related]
16. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
[TBL] [Abstract][Full Text] [Related]
17. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
[TBL] [Abstract][Full Text] [Related]
18. In vitro antimicrobial activity of fluoroquinolones against clinical isolates obtained in 1989 and 1990.
Chen YC; Chang SC; Hsu LY; Hsieh WC; Luh KT
J Formos Med Assoc; 1993 Dec; 92(12):1040-8. PubMed ID: 7911351
[TBL] [Abstract][Full Text] [Related]
19. [Antibacterial activities of ofloxacin against recent clinical isolates from patients with ocular infections].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1993 May; 46(5):349-63. PubMed ID: 8326675
[TBL] [Abstract][Full Text] [Related]
20. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
